共 25 条
[1]
The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Arch. Intern. Med., 157, pp. 2413-2446, (1997)
[2]
Berlowitz D.R., Ash A.S., Hickey E.C., Friedman R.H., Glickman M., Kader B., Moskowitz M.A., Inadequate management of blood pressure in a hypertensive population, N. Engl. J. Med., 339, pp. 1957-1963, (1998)
[3]
Hyman D.J., Pavlik V.N., Self-reported hypertension treatment practices among primary care physicians: Blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine, Arch. Intern. Med., 160, pp. 2281-2286, (2000)
[4]
Oliveria S.A., Lapuerta P., McCarthy B.D., L'Italien G.J., Berlowitz D.R., Asch S.M., Physician-related barriers to the effective management of uncontrolled hypertension, Arch. Intern. Med., 162, pp. 413-420, (2002)
[5]
Hajjar I., Kotchen T.A., Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000, JAMA, 290, pp. 199-206, (2003)
[6]
Sundquist J., Winkleby M.A., Pudaric S., Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: An analysis of NHANES III, 1988-1994. Third National Health and Nutrition Examination Survey, J. Am. Geriatr. Soc., 49, pp. 109-116, (2001)
[7]
Hyman D.J., Pavlik V.N., Characteristics of patients with uncontrolled hypertension in the United States, N. Engl. J. Med., 345, pp. 479-486, (2001)
[8]
Materson B.J., Lessons on the interaction of race and antihypertensive drugs from the VA cooperative study group on anti-hypertensive agents, Am. J. Hypertension, 8, (1995)
[9]
Richardson A.D., Piepho R.W., Effect of race on hypertension and anti-hypertensive therapy, Int. J. Clin. Pharm. Ther., 38, pp. 75-79, (2000)
[10]
He J., Klag M.J., Caballero B., Appel L.J., Charleston J., Whelton P.K., Plasma insulin levels and incidence of hypertension in African Americans and Whites, Arch. Intern. Med., 159, pp. 498-503, (1999)